Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.

J Clin Med · 2022 · PMC9225266 · PMID 35743426

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significancep = 0.15not close (p > 0.1)

There were no significant differences in the baseline characteristics between the two groups, except from platelet count, which was marginally higher in controls ( p < 0.05); bone marrow infiltration was marginally higher in the TMA group, although this difference did not reach statistical significance ( p = 0.15).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.